Label: FEXOFENADINE HYDROCHLORIDE tablet

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated November 12, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient (in each tablet)

    Fexofenadine HCl USP, 180 mg

  • Purpose

    Antihistamine

  • Uses

    temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

    • runny nose
    • itchy, watery eyes
    • sneezing
    • itching of the nose or throat



  • Warnings

    Do not use

    if you have ever had an allergic reaction to this product or any of its ingredients.

    Ask a doctor before use if you have

    kidney disease. Your doctor should determine if you need a different dose.

    When using this product

    • do not take more than directed
    • do not take at the same time as aluminum or magnesium antacids
    • do not take with fruit juices (see Directions)

    Stop use and ask doctor if

    an allergic reaction to this product occurs. Seek medical help right away.

    If pregnant or breast-feeding,

    ask a health professional before use.

    Keep out of reach of children.

    In case of  overdose, get medical help or contact a Poison Control Center right away.

  • Directions

    adults and children 12 years of age and over         take one 180 mg tablet with water once a day; do not take more than 1 tablet in 24 hours
    children under 12 years of agedo not use
    adults 65 years of age  and olderask a doctor
    consumers with kidney diseaseask a doctor
  • Other information

    • safety sealed: do not use if carton is opened or if printed foil inner seal on bottle is torn or missing
    • store between 20° and 25°C (68° and 77°F)
    • protect from excessive moisture
    • this product meets the requirements of USP Dissolution Test 4

  • Inactive ingredients

    colloidal silicon dioxide, corn starch, croscarmellose sodium, FD&C Red no. 40, hypromellose, iron oxide black, magnesium stearate, mannitol, polyethylene glycol, powder cellulose and titantium dioxide

  • Questions?

    call 1-888-375-3784

  • Package Label - 30 Count Carton

    MAJOR

    COMPARE TO active ingredient of
    ALLEGRA® ALLERGY 24 HOUR TABLETS*

    NDC 0904-6711-46

    Original Prescription Strength

    FEXOFENADINE
    HYDROCHLORIDE Tablets USP, 180 mg
    Antihistamine

    ALLERGY

    Relief of:

    • Sneezing
    • Runny Nose
    • Itchy, Watery Eyes
    • Itchy Nose or Throat

    Non-Drowsy

    Indoor & Outdoor
    Allergies

    24
    HOUR

    30 TABLETS
    180 mg EACH

    Carton


  • Package Label - 30 Count Bottle

    MAJOR NDC 0904-6711-46

    Original Prescription Strength

    FEXOFENADINE
    HYDROCHLORIDE
    Tablets USP, 180 mg / Antihistamine

    ALLERGY

    Indoor & Outdoor Allergies

    Non-Drowsy

    24
    HOUR

    30 TABLETS
    180 mg EACH

    Bottle

  • INGREDIENTS AND APPEARANCE
    FEXOFENADINE HYDROCHLORIDE 
    fexofenadine hydrochloride tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0904-6711(NDC:55111-784)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    Fexofenadine Hydrochloride (UNII: 2S068B75ZU) (FEXOFENADINE - UNII:E6582LOH6V) Fexofenadine Hydrochloride180 mg
    Inactive Ingredients
    Ingredient NameStrength
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    magnesium stearate (UNII: 70097M6I30)  
    mannitol (UNII: 3OWL53L36A)  
    POWDERED CELLULOSE (UNII: SMD1X3XO9M)  
    FD&C RED NO. 40 (UNII: WZB9127XOA)  
    HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)  
    FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
    polyethylene glycol 400 (UNII: B697894SGQ)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    Product Characteristics
    ColorPINKScoreno score
    ShapeOVALSize7mm
    FlavorImprint Code 194;R
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0904-6711-461 in 1 CARTON04/27/2018
    130 in 1 BOTTLE; Type 0: Not a Combination Product
    2NDC:0904-6711-522 in 1 CARTON04/27/201810/30/2022
    230 in 1 BOTTLE; Type 0: Not a Combination Product
    3NDC:0904-6711-103 in 1 CARTON04/27/201810/30/2022
    35 in 1 BLISTER PACK; Type 0: Not a Combination Product
    4NDC:0904-6711-891 in 1 CARTON04/27/201810/30/2022
    490 in 1 BOTTLE; Type 0: Not a Combination Product
    5NDC:0904-6711-921 in 1 CARTON04/27/201810/30/2022
    5150 in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA07650204/27/2018
    Labeler - MAJOR PHARMACEUTICALS (191427277)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!